Lipoxin A4 - Moligand™, ≥95%, 100µg/ml in ethanol , Agonist of FPR2/ALX;Agonist of FPR3;Agonist of GPR32, CAS No.89663-86-5, Agonist of FPR2/ALX;Agonist of FPR3;Agonist of GPR32

CAS: 89663-86-5 Cat. No.: L345922 Summenformel: C20H32O5 Molekulargewicht: 352.47 EG-Nummer: 200-578-6
Zu bestellen verfügbar
QUALITÄT & REINHEIT Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥95% 100µg/ml in ethanol
Synonyms
(7E,9E,11Z,13E)-(5S,6R,15S)-5,6,15-Trihydroxyicosa-7,9,11,13-tetraenoate|7,9,11,13-Eicosatetraenoic acid, 5,6,15-trihydroxy-, (5S,6R,7E,9E,11Z,13E,15S)-|(5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyeicosa-7,9,11,13-tetraenoic acid|(5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid|5S,6S-Lipoxin A4|5(S),6(R),15(S)-trihydroxyeicosa-7E,9E,11Z,13E-tetraenoic acid|LXA4|5,6,15-triHETE|7,9,11,13-Eicosatetraenoicacid, 5,6,15-trihydroxy-, (5S,6R,7E,9E,11Z,13E,15S)-|5S,6R,15S-Trihydroxy-7E,9E,11Z,13E-eicosatetraenoate|5S,6R-LipoxinA4|LXA4-[19,19,20,20,20-d5]|5S,6R,15S-trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid|lipoxin A4|(5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxy-7,9,11,13-eicosatetraenoic acid|(7E,9E,11Z,13E)-(5S,6R,15S)-5,6,15-Trihydroxyicosa-7,9,11,13-tetraenoic acid|(5S,6R,15S)-trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid|5S,6R,15S-trihydroxy-7E,9E,11Z,13E-Eicosatetraenoic acid|Lipoxin A
Storage
Argon charged,Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Größe
Deutschland (EU)
USA*
Preis
Menge
25μg
L345922-25μg
Auf Bestellung · 8–12 Wochen
728,81€
50μg
L345922-50μg
Auf Bestellung · 8–12 Wochen
1.353,59€
Enter a quantity for the sizes you want to add.

Übersicht

Lipoxin A4 (LXA4), an endogenous lipoxygenase-derived eicosanoid mediator, has potent dual pro-resolving and anti-inflammatory properties. Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes (NHEKs) associated with the ERK1/2 and NF-kB pathways. Lipoxin A4 inhibits serum amyloid A (SAA)-mediated IL-8 release with an IC50 value of 25.74 nM.

Spezifikationen

Synonyme
(7E,9E,11Z,13E)-(5S,6R,15S)-5,6,15-Trihydroxyicosa-7,9,11,13-tetraenoate | 7,9,11,13-Eicosatetraenoic acid, 5,6,15-trihydroxy-, (5S,6R,7E,9E,11Z,13E,15S)- | (5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyeicosa-7,9,11,13-tetraenoic acid | (5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid | 5S,6S-Lipoxin A4 | 5(S),6(R) Show more
Spezifikationen & Reinheit
Moligand™, ≥95%, 100µg/ml in ethanol
Biochemische und physiologische Mechanismen
Lipoprotein A4 (LXA4) is synthesized from arachidonic acid and is an endogenous lipoxygenase derived arachidonic acid mediator. It is an effective activator of human protein kinase C. It inhibits the cytotoxicity of natural killer cells. LXA4 regulates the immune system and inflammation. In the brain, it regulates neuronal signal transduction and slow wave sleep. LXA4 binds to cannabinoid receptors. LXA4 plays a crucial role in the maintenance of the endometrium and reproductive function. The consumption of LXA4 contributes to the pathophysiology of cystic fibrosis (CF).
Storage
Argon charged,Store at -80°C
Verschickt in
Dry ice packs + Cold packs
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Note
Moligand™
Aktionsart
AGONIST
Mechanismus der Wirkung
Agonist of FPR2/ALX;Agonist of FPR3;Agonist of GPR32
Hinweis
Store as supplied at -80° C for up to 1 year.
Reinheit
≥95%
Produkteigenschaften
pKa
pKa: 4.67
Namen und Kennungen
SMILES
CCCCCC(C=CC=CC=CC=CC(C(CCCC(=O)O)O)O)O
IUPAC Name
(5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid
InChIKey
IXAQOQZEOGMIQS-SSQFXEBMSA-N
InChI
1S/C20H32O5/c1-2-3-8-12-17(21)13-9-6-4-5-7-10-14-18(22)19(23)15-11-16-20(24)25/h4-7,9-10,13-14,17-19,21-23H,2-3,8,11-12,15-16H2,1H3,(H,24,25)/b6-4-,7-5+,13-9+,14-10+/t17-,18+,19-/m0/s1
Isomere SMILES
CCCCC[C@@H](/C=C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)O)O
WGK Deutschland
2
Molekulargewicht
352.47
Reaxy-Rn
34893640
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=34893640&ln=

Erweiterte Daten

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassLipids and lipid-like molecules
KlasseFatty Acyls
SubclassEicosanoids
Intermediate Tree Nodes Hydroxyeicosatetraenoic acids
Direct ParentLipoxins
Alternative Parents Long-chain fatty acids  Hydroxy fatty acids  Unsaturated fatty acids  Secondary alcohols  Polyols  Monocarboxylic acids and derivatives  Carboxylic acids  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular FrameworkAliphatic acyclic compounds
Substituents Lipoxin - Long-chain fatty acid - Hydroxy fatty acid - Fatty acid - Unsaturated fatty acid - Secondary alcohol - Carboxylic acid derivative - Carboxylic acid - Monocarboxylic acid or derivatives - Polyol - Organic oxide - Organic oxygen compound - Hydrocarbon derivative - Carbonyl group - Organooxygen compound - Alcohol - Aliphatic acyclic compound
BeschreibungThis compound belongs to the class of organic compounds known as lipoxins. These are eicosanoids with a trihydroxyicosatetraenoic acid skeleton (a c20-fatty acid, with the chain bearing three hydroxyl groups and four double bonds). Lipoxins have four double bonds, which are all conjugated. In some cases a hydroxyl group is substituted by a C=O group.
External Descriptors Lipoxins
3D-Struktur
Interaktives chemisches Strukturmodell





Zugehörige Ziele (menschlich)
GPR32 Tchem Probable G-protein coupled receptor 32 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
FPR2 Tchem N-formyl peptide receptor 2 (7 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
FPR3 Tchem N-formyl peptide receptor 3 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FPR2 Tchem Lipoxin A4 receptor (3472 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NFKB2 Tchem Nuclear factor NF-kappa-B complex (2307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Zugehörige Ziele (nicht menschlich)
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Wirkungsmechanismen
Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

1 results found

Lot NumberCertificate TypeDatumArtikel
I2404555I2404555Certificate of AnalysisAug 29, 2024 L345922
Chemische und physikalische Eigenschaften
LöslichkeitSoluble in ethanol, DMSO (≥50 mg/ml), DMF (≥50 mg/ml), and PBS (pH 7.2) (≥1 mg/ml).
Brechungsindexn20D1.54
Siedepunkt (°C)78° C
Molekulargewicht352.500 g/mol
XLogP33.100
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count5
Rotatable Bond Count14
Exact Mass352.225 Da
Monoisotopic Mass352.225 Da
Topological Polar Surface Area98.000 Ų
Heavy Atom Count25
Formal Charge0
Complexity451.000
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count4
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds4
Covalently-Bonded Unit Count1
Citations of This Product
Lösungsrechner
Bewertungen

Kundenbewertungen

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.